Urinary alpha 1- and beta 2-microglobulin in light chain proteinuria

Area of Science:

• Nephrology
• Hematology
• Biochemistry

Background:

• Light chain (LC) proteinuria is associated with kidney damage in patients with plasma cell disorders.
• Assessing renal function in these patients is crucial for management.
• Urinary biomarkers may aid in monitoring kidney health.

Purpose of the Study:

• To evaluate the utility of urinary alpha 1-microglobulin (alpha 1M) as an indicator of renal damage in patients with light chain proteinuria.
• To correlate urinary alpha 1M excretion with other markers of kidney function and LC excretion.

Main Methods:

• Prospective follow-up of 13 patients with LC proteinuria (multiple myeloma or monoclonal gammopathy of undetermined significance).
• Regular monitoring of urinary LCs, alpha 1M, beta 2-microglobulin (beta 2M), albumin, and serum creatinine.
• Statistical analysis to assess correlations between markers and renal function stability.

Main Results:

• Urinary alpha 1M excretion correlated with LC excretion and serum creatinine at baseline.
• Stable renal function was observed in 8/13 patients with predominantly low urinary alpha 1M (<150 mg/24 h).
• Unstable renal function in 5/13 patients was associated with high urinary alpha 1M (>150 mg/24 h), despite comparable LC and albumin excretion.

Conclusions:

• Urinary alpha 1M is a valuable biomarker for detecting renal damage caused by light chains.
• Monitoring urinary alpha 1M levels can help predict or identify kidney injury in patients with LC proteinuria.
• This marker aids in distinguishing stable from unstable renal function in this patient population.